Absolute and relative changes in patients’ characteristics at 6-month follow-up according to the vital status of the patient
6-month changes in . | Survivors without transplant n = 74 . | Death or transplant n = 21 . | P-value . |
---|---|---|---|
BNP (pg/mL) | −118.1 ± 232.9 | +231.2 ± 485.7 | 0.004 |
3D RV EF (%) | +5.6 ± 9.4 | −3.8 ± 10.4 | 0.0004 |
Relative change (%E1) | +20.8 ± 37.9 | −7.5 ± 28.0 | 0.001 |
3D RV EDV (mL) | −3.4 ± 35.0 | +23.7 ± 46.1 | 0.02 |
Relative change (%E1) | +6.6 ± 37.6 | +29.2 ± 51.0 | 0.03 |
Global RV area strain (%) | −3.8 ± 6.7 | +3.6 ± 6.7 | 0.0001 |
Relative change (%E1) | +10.4 ± 35.6 | −45.1 ± 75.9 | 0.0001 |
Global RV circumferential strain (%) | −1.9 ± 4.3 | +2.4 ± 4.5 | 0.0005 |
Relative change (%E1) | +23.4 ± 47.6 | −15.6 ± 32.9 | 0.0006 |
Global RV longitudinal strain (%) | −2.2 ± 4.5 | +1.4 ± 3.6 | 0.001 |
Relative change (%E1) | +61.5 ± 174.7 | −15.0 ± 50.6 | 0.001 |
TAPSE (mm) | +0.0 ± 6.9 | −0.2 ± 6.3 | 0.52 |
Relative change (%E1) | +5.7 ± 29.6 | −6.2 ± 26.5 | 0.11 |
S’ (cm/s) | +0.7 ± 2.0 | −0.3 ± 2.5 | 0.08 |
Relative change (%E1) | +8.0 ± 17.8 | −0.01 ± 26.1 | 0.14 |
RA area (cm2) | −1.4 ± 6.7 | +3.4 ± 9.4 | 0.05 |
Relative change (%E1) | −2.0 ± 23.6 | +9.0 ± 19.2 | 0.07 |
LV EF (%) | −0.62 ± 17.3 | −0.26 ± 23.8 | 0.94 |
Relative change (%E1) | −2.8 ± 20.7 | −4 ± 27.5 | 0.88 |
LV EDD (mm) | +0.2 ± 1.3 | −0.2 ± 1.5 | 0.26 |
Relative change (%E1) | +0.5 ± 2.9 | −0.4 ± 3.4 | 0.25 |
6-month changes in . | Survivors without transplant n = 74 . | Death or transplant n = 21 . | P-value . |
---|---|---|---|
BNP (pg/mL) | −118.1 ± 232.9 | +231.2 ± 485.7 | 0.004 |
3D RV EF (%) | +5.6 ± 9.4 | −3.8 ± 10.4 | 0.0004 |
Relative change (%E1) | +20.8 ± 37.9 | −7.5 ± 28.0 | 0.001 |
3D RV EDV (mL) | −3.4 ± 35.0 | +23.7 ± 46.1 | 0.02 |
Relative change (%E1) | +6.6 ± 37.6 | +29.2 ± 51.0 | 0.03 |
Global RV area strain (%) | −3.8 ± 6.7 | +3.6 ± 6.7 | 0.0001 |
Relative change (%E1) | +10.4 ± 35.6 | −45.1 ± 75.9 | 0.0001 |
Global RV circumferential strain (%) | −1.9 ± 4.3 | +2.4 ± 4.5 | 0.0005 |
Relative change (%E1) | +23.4 ± 47.6 | −15.6 ± 32.9 | 0.0006 |
Global RV longitudinal strain (%) | −2.2 ± 4.5 | +1.4 ± 3.6 | 0.001 |
Relative change (%E1) | +61.5 ± 174.7 | −15.0 ± 50.6 | 0.001 |
TAPSE (mm) | +0.0 ± 6.9 | −0.2 ± 6.3 | 0.52 |
Relative change (%E1) | +5.7 ± 29.6 | −6.2 ± 26.5 | 0.11 |
S’ (cm/s) | +0.7 ± 2.0 | −0.3 ± 2.5 | 0.08 |
Relative change (%E1) | +8.0 ± 17.8 | −0.01 ± 26.1 | 0.14 |
RA area (cm2) | −1.4 ± 6.7 | +3.4 ± 9.4 | 0.05 |
Relative change (%E1) | −2.0 ± 23.6 | +9.0 ± 19.2 | 0.07 |
LV EF (%) | −0.62 ± 17.3 | −0.26 ± 23.8 | 0.94 |
Relative change (%E1) | −2.8 ± 20.7 | −4 ± 27.5 | 0.88 |
LV EDD (mm) | +0.2 ± 1.3 | −0.2 ± 1.5 | 0.26 |
Relative change (%E1) | +0.5 ± 2.9 | −0.4 ± 3.4 | 0.25 |
BNP, brain natriuretic peptide; EDV, end-diastolic volume; EF, ejection fraction; LV, left ventricular; RA, right atrial; RV, right ventricular.
P-value was obtained using Student’s t-test.
Absolute and relative changes in patients’ characteristics at 6-month follow-up according to the vital status of the patient
6-month changes in . | Survivors without transplant n = 74 . | Death or transplant n = 21 . | P-value . |
---|---|---|---|
BNP (pg/mL) | −118.1 ± 232.9 | +231.2 ± 485.7 | 0.004 |
3D RV EF (%) | +5.6 ± 9.4 | −3.8 ± 10.4 | 0.0004 |
Relative change (%E1) | +20.8 ± 37.9 | −7.5 ± 28.0 | 0.001 |
3D RV EDV (mL) | −3.4 ± 35.0 | +23.7 ± 46.1 | 0.02 |
Relative change (%E1) | +6.6 ± 37.6 | +29.2 ± 51.0 | 0.03 |
Global RV area strain (%) | −3.8 ± 6.7 | +3.6 ± 6.7 | 0.0001 |
Relative change (%E1) | +10.4 ± 35.6 | −45.1 ± 75.9 | 0.0001 |
Global RV circumferential strain (%) | −1.9 ± 4.3 | +2.4 ± 4.5 | 0.0005 |
Relative change (%E1) | +23.4 ± 47.6 | −15.6 ± 32.9 | 0.0006 |
Global RV longitudinal strain (%) | −2.2 ± 4.5 | +1.4 ± 3.6 | 0.001 |
Relative change (%E1) | +61.5 ± 174.7 | −15.0 ± 50.6 | 0.001 |
TAPSE (mm) | +0.0 ± 6.9 | −0.2 ± 6.3 | 0.52 |
Relative change (%E1) | +5.7 ± 29.6 | −6.2 ± 26.5 | 0.11 |
S’ (cm/s) | +0.7 ± 2.0 | −0.3 ± 2.5 | 0.08 |
Relative change (%E1) | +8.0 ± 17.8 | −0.01 ± 26.1 | 0.14 |
RA area (cm2) | −1.4 ± 6.7 | +3.4 ± 9.4 | 0.05 |
Relative change (%E1) | −2.0 ± 23.6 | +9.0 ± 19.2 | 0.07 |
LV EF (%) | −0.62 ± 17.3 | −0.26 ± 23.8 | 0.94 |
Relative change (%E1) | −2.8 ± 20.7 | −4 ± 27.5 | 0.88 |
LV EDD (mm) | +0.2 ± 1.3 | −0.2 ± 1.5 | 0.26 |
Relative change (%E1) | +0.5 ± 2.9 | −0.4 ± 3.4 | 0.25 |
6-month changes in . | Survivors without transplant n = 74 . | Death or transplant n = 21 . | P-value . |
---|---|---|---|
BNP (pg/mL) | −118.1 ± 232.9 | +231.2 ± 485.7 | 0.004 |
3D RV EF (%) | +5.6 ± 9.4 | −3.8 ± 10.4 | 0.0004 |
Relative change (%E1) | +20.8 ± 37.9 | −7.5 ± 28.0 | 0.001 |
3D RV EDV (mL) | −3.4 ± 35.0 | +23.7 ± 46.1 | 0.02 |
Relative change (%E1) | +6.6 ± 37.6 | +29.2 ± 51.0 | 0.03 |
Global RV area strain (%) | −3.8 ± 6.7 | +3.6 ± 6.7 | 0.0001 |
Relative change (%E1) | +10.4 ± 35.6 | −45.1 ± 75.9 | 0.0001 |
Global RV circumferential strain (%) | −1.9 ± 4.3 | +2.4 ± 4.5 | 0.0005 |
Relative change (%E1) | +23.4 ± 47.6 | −15.6 ± 32.9 | 0.0006 |
Global RV longitudinal strain (%) | −2.2 ± 4.5 | +1.4 ± 3.6 | 0.001 |
Relative change (%E1) | +61.5 ± 174.7 | −15.0 ± 50.6 | 0.001 |
TAPSE (mm) | +0.0 ± 6.9 | −0.2 ± 6.3 | 0.52 |
Relative change (%E1) | +5.7 ± 29.6 | −6.2 ± 26.5 | 0.11 |
S’ (cm/s) | +0.7 ± 2.0 | −0.3 ± 2.5 | 0.08 |
Relative change (%E1) | +8.0 ± 17.8 | −0.01 ± 26.1 | 0.14 |
RA area (cm2) | −1.4 ± 6.7 | +3.4 ± 9.4 | 0.05 |
Relative change (%E1) | −2.0 ± 23.6 | +9.0 ± 19.2 | 0.07 |
LV EF (%) | −0.62 ± 17.3 | −0.26 ± 23.8 | 0.94 |
Relative change (%E1) | −2.8 ± 20.7 | −4 ± 27.5 | 0.88 |
LV EDD (mm) | +0.2 ± 1.3 | −0.2 ± 1.5 | 0.26 |
Relative change (%E1) | +0.5 ± 2.9 | −0.4 ± 3.4 | 0.25 |
BNP, brain natriuretic peptide; EDV, end-diastolic volume; EF, ejection fraction; LV, left ventricular; RA, right atrial; RV, right ventricular.
P-value was obtained using Student’s t-test.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.